GSK lifts guidance as Q3 beats expectations
2nd Nov 2022 07:30
(Sharecast News) - UK pharma giant GSK lifted full-year guidance after beating third-quarter expectations with an 18% rise in revenues driven by its Shingrix shingles treatment.
Read moreGSK rises as EMA gives nod to RSV, HIV candidates
28th Oct 2022 10:04
(Sharecast News) - Shares in pharmaceuticals giant GSK were in the green on Friday morning, after the European Medicines Agency (EMA) accepted marketing authorisation applications for RSV and HIV.
Read moreGSK abandons regulatory submissions of rheumatoid arthritis drug
27th Oct 2022 07:30
(Sharecast News) - Drugmaker GSK revealed on Thursday that it will not proceed with regulatory submissions of its experimental treatment for moderate-to-severe rheumatoid arthritis after the drug candidate failed to meet a key endpoint in a recent study.
Read moreGSK seeks Japanese approval for respiratory disease vaccine
21st Oct 2022 08:24
(Sharecast News) - Japan's medicines regulator has agreed to review GSK's vaccine candidate for respiratory disease, the UK drugs group said on Friday.
Read moreGlaxoSmithKline receives FDA approval for new presentation of Menveo asset
17th Oct 2022 07:10
(Sharecast News) - Drugmaker GlaxoSmithKline has received Food and Drug Administration approval for a new presentation of its invasive meningococcal disease vaccine.
Read moreGSK reports 'exceptional' result from respiratory drug trial
13th Oct 2022 07:40
(Sharecast News) - Pharma giant GSK said its respiratory syncytial virus (RSV) vaccine was 82.6% effective, according to phase 3 trial data from a study of older adults.
Read moreUS green lights GSK vaccine for use during pregnancy
10th Oct 2022 07:58
(Sharecast News) - GSK's whooping cough vaccine has been approved for use in pregnant women in the US.
Read moreGSK looks to Burberry for new CFO
26th Sep 2022 08:21
(Sharecast News) - GSK has named Burberry Group's Julie Brown as its new chief financial officer.
Read moreGSK takes stake in Spero in deal on UTI treatment
22nd Sep 2022 07:47
(Sharecast News) - UK pharmaceutical company GSK is taking a stake in Spero Therapeutics as part of a licensing agreement for the US-based drug developer's experimental antibiotic for complicated urinary tract infections.
Read moreCredit Suisse upgrades GSK, downgrades AstraZeneca
15th Sep 2022 13:49
(Sharecast News) - Credit Suisse upgraded GlaxoSmithKline on Thursday but downgraded AstraZeneca as it took a look at the pharmaceuticals sector.
Read moreCiti puts GSK on 'positive catalyst watch', cites Zantac litigation developments
26th Aug 2022 09:10
(Sharecast News) - Citigroup put pharmaceuticals company GlaxoSmithKline on "positive catalyst watch" on Friday as it pointed to legal developments related to the company's now-discontinued Zantac heartburn drug.
Read moreGSK application for myelofibrosis drug accepted by US FDA
17th Aug 2022 07:54
(Sharecast News) - The US Food and Drug administration has accepted a new drug application for GlaxoSmithKline's treatment for myelofibrosis patients with anaemia, the company said on Wednesday.
Read morePlaintiff in GSK Zantac lawsuit pulls suit for now
17th Aug 2022 07:37
(Sharecast News) - GlaxoSmithKline said the plaintiff in the first lawsuit over the heartburn drug Zantac to go to trial had agreed to drop his case for now.
Read moreGSK to 'vigorously defend' Zantac claims; Haleon says not a party to claims
12th Aug 2022 07:26
(Sharecast News) - GlaxoSmithKline said on Friday that it would "vigorously defend" all claims related to its discontinued heartburn drug Zantac.
Read moreGSK, Haleon, Sanofi slump amid Zantac litigation woes
11th Aug 2022 12:35
(Sharecast News) - Shares in GlaxoSmithKline, Haleon and Sanofi tumbled on Thursday amid concerns about legal proceedings related to Glaxo's former blockbuster heartburn drug Zantac.
Read more